Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Genitourinary 30 Gastrointestinal 10 Thoracic 7 Tumor-Agnostic 5 Head & Neck 4 Dermatologic 4 Endocrine 3 CNS 3 Sarcoma 2 Other solid neoplasm 2 Gynecologic 2 Other hematologic neoplasm 1 NET 1 Myeloid 1 Lymphoid 1 Breast 1

Conditions

Lymphoma, Mantle-Cell 1 Carcinoma 1

Interventions

Rituximab 530 Cyclophosphamide 425 Vincristine 219 Doxorubicin 192 fludarabine phosphate 177 Etoposide 167 Prednisone 166 fludarabine 162 Methotrexate 162 Cytarabine 157 Filgrastim 125 Dexamethasone 123 Lenalidomide 121 Granulocyte Colony-Stimulating Factor 116 Whole-Body Irradiation 107 Mycophenolic Acid 99 ibrutinib 97 Bendamustine Hydrochloride 91 Tacrolimus 88 Melphalan 85 Calcium Dobesilate 82 Peripheral Blood Stem Cell Transplantation 80 Bortezomib 80 Busulfan 78 obinutuzumab 64 ofatumumab 59 Radiotherapy 57 Cyclosporine 57 Antilymphocyte Serum 55 Brentuximab Vedotin 54

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Axitinib × Lymphoid × Clear all

NCT00700258 2024-09-23

STAR-TOR

Pfizer

1,520 enrolled 24 charts

Carcinoma, Lymphoma, Mantle-Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡